CHM chimeric therapeutics limited

Ann: Sponsored Research Agreement with University of Pennsylvania, page-4

  1. 5,714 Posts.
    lightbulb Created with Sketch. 1749
    The announcement is not capable of being marked price sensitive as it gives no financial details around the sponsorship agreement. Either this is because they remain subject to negotiation and/or because they are considered trade sensitive by either party. Additionally the "first right of negotiation to license Penn intellectual property arising from the conduct of the sponsored research" is an agreement for a potential future negotiation of purchase of IP and therefor the ASX would not consider that information price sensitive.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $10.32K 2.580M

Buyers (Bids)

No. Vol. Price($)
3 4130543 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 18587873 22
View Market Depth
Last trade - 11.38am 27/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.